CD44 and prostate carcinoma: Whereas prostate cancer cell lines have less than a 2% progenitor population when cultured under long-term monolayer culture conditions, prostate cancer progenitor populations expressing CD44 and CD133 cell surface markers can be significantly enriched when grown under sphere-forming conditions [5], [11].